See also this year's filing and all EDGAR filings for this company.
PDF Report 0001566044_2023_VYNE_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001566044, VYNE Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 38,275,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 2,483,000 |
4 | LiabilitiesCurrent | 0 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 9,345,000 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 16,387,000 |
9 | ResearchAndDevelopmentExpense | 18,385,000 |
10 | remainder_Expenses | 13,000 |
11 | remainder_Revenues | 477,000 |
12 | remainder_NetIncome | 11,098,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 40,758,000 |
1 | Liabilities | 9,345,000 |
2 | Expenses | 34,785,000 |
3 | Revenues | 477,000 |
4 | StockholdersEquity | 31,413,000 |
5 | NetIncome | -23,210,000 |
6 | ComprehensiveNetIncome | -23,210,000 |
7 | BaseVar | 48,231,500 |
8 | EconomicCapitalRatio | 1.23 |